Anastasia Smirnova

Ms. Anastasia Smirnova

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
SUShamil Urazbakhtin
Shamil Urazbakhtin
ASAnastasia Smirnova
Anastasia Smirnova
AVAnastasiya Volakhava
Anastasiya Volakhava
EZElena Zerkalenkova
Elena Zerkalenkova
MSMaria Salyutina
Maria Salyutina
IMIlgar Z. Mamedov
Ilgar Z. Mamedov
Retroelements (RE) have been proposed as important players in cancerogenesis. Different cancer types are characterized by a different level of tumor-specific RE insertions. In previous studies, small cohorts of hematological malignancies, such as acute myeloid leukemia, multiple myeloma, and chronic lymphocytic leukemia have been characterized by a low level of RE insertional activity. Acute lymphoblastic leukemia (ALL) in adults and childhood acute leukemias have not been studied in this context. We performed a search for new RE insertions (Alu and L1) in 44 childhood ALL, 14 childhood acute myeloid leukemia, and 14 adult ALL samples using a highly sensitive NGS-based approach. First, we evaluated the method sensitivity revealing the 1% detection threshold for the proportion of cells with specific RE insertion. Following this result, we did not identify new tumor-specific RE insertions in the tested cohort of acute leukemia samples at the established level of sensitivity. Additionally, we analyzed the transcription levels of active L1 copies and found them increased. Thus, the increased transcription of active L1 copies is not sufficient for overt elevation of L1 retrotranspositional activity in leukemia.

16 November 2024 in Cancers
Verified
Journal Article
Open access
PDF file
GZGalina Sergeevna Zakharova
Galina Sergeevna Zakharova
MSMaria Suntsova
Maria Suntsova
ERElizaveta Rabushko
Elizaveta Rabushko
Tharaa MohammadTharaa Mohammad
Tharaa Mohammad
ADAlexey Drobyshev
Alexey Drobyshev
ABAnton A. Buzdin
Anton A. Buzdin
Background: In clinical practice, various methods are used to identify ALK gene rearrangements in tumor samples, ranging from “classic” techniques, such as IHC, FISH, and RT-qPCR, to more advanced highly multiplexed approaches, such as NanoString technology and NGS panels. Each of these methods has its own advantages and disadvantages, but they share the drawback of detecting only a restricted (although sometimes quite extensive) set of preselected biomarkers. At the same time, whole transcriptome sequencing (WTS, RNAseq) can, in principle, be used to detect gene fusions while simultaneously analyzing an incomparably wide range of tumor characteristics. However, WTS is not widely used in practice due to purely analytical limitations and the high complexity of bioinformatic analysis, which requires considerable expertise. In particular, methods to detect gene fusions in RNAseq data rely on the identification of chimeric reads. However, the typically low number of true fusion reads in RNAseq limits its sensitivity. In a previous study, we observed asymmetry in the RNAseq exon coverage of the 3′ partners of some fusion transcripts. In this study, we conducted a comprehensive evaluation of the accuracy of ALK fusion detection through an analysis of differences in the coverage of its tyrosine kinase exons. Methods: A total of 906 human cancer biosamples were subjected to analysis using experimental RNAseq data, with the objective of determining the extent of asymmetry in ALK coverage. A total of 50 samples were analyzed, comprising 13 samples with predicted ALK fusions and 37 samples without predicted ALK fusions. These samples were assessed by targeted sequencing with two NGS panels that were specifically designed to detect fusion transcripts (the TruSight RNA Fusion Panel and the OncoFu Elite panel). Results: ALK fusions were confirmed in 11 out of the 13 predicted cases, with an overall accuracy of 96% (sensitivity 100%, specificity 94.9%). Two discordant cases exhibited low ALK coverage depth, which could be addressed algorithmically to enhance the accuracy of the results. It was also important to consider read strand specificity due to the presence of antisense transcripts involving parts of ALK. In a limited patient sample undergoing ALK-targeted therapy, the algorithm successfully predicted treatment efficacy. Conclusions: RNAseq exon coverage analysis can effectively detect ALK rearrangements.

15 March 2026 in Nature Communications
Verified
Journal Article
Open access
STStanislav Terekhov
Stanislav Terekhov
NINikita V. Ivanisenko
Nikita V. Ivanisenko
NZNan Zhang
Nan Zhang
YMYuliana A. Mokrushina
Yuliana A. Mokrushina
DNDmitry E Nolde
Dmitry E Nolde
RKRoger D. Kornberg
Roger D. Kornberg
Despite substantial progress in single-cell screening techniques, antibody (Ab) repertoires still remain enigmatic. Here we show that Ab sequences can be linked to their functionality by using big data obtained from high-throughput sequencing. Using the expansive SARS-CoV-2 pandemic data, we develop an AI-based method to reveal the neutralization potential of Ab repertoires. We employ machine learning to process public 3D structural data of Ab-RBD complexes and create a comprehensive tool, RBD-AIM (https://rbdaim.2a2i.org/), for high-throughput prediction of structural Ab epitopes based on Ab sequence. Using RBD-AIM, we analyze the local big data sources to evaluate the functional biodiversity of native B cell repertoires raised after vaccination and reconstructed in a yeast display system using single-cell microfluidics. This pipeline allows for rapid isolation of neutralizing Abs that promote the survival of transgenic hACE2+ mice in lethal models of SARS-CoV-2 infection. We believe that the AI-guided sequence-functionality link can be successfully employed for further high-throughput discovery of therapeutic Abs and functional analysis of Ab repertoires.